Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

about

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

Item

http://www.wikidata.org/entity/Q52629218

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

@en

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

@nl

type

Item

label

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

@en

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

@nl

prefLabel

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

@en

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.

@nl

P1476

Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible

@en

P2093

Charilaos Koulouris

http://www.w3.org/2001/XMLSchema#string

Chong Bai

http://www.w3.org/2001/XMLSchema#string

Chrysanthi Karapantzou

http://www.w3.org/2001/XMLSchema#string

Dimitris Giannakidis

http://www.w3.org/2001/XMLSchema#string

Haidong Huang

http://www.w3.org/2001/XMLSchema#string

Ilias Karapantzos

http://www.w3.org/2001/XMLSchema#string

Isaak Kesisoglou

http://www.w3.org/2001/XMLSchema#string

Konstantina Boniou

http://www.w3.org/2001/XMLSchema#string

Konstantinos Sapalidis

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature

Clinical experimentation with aerosol antibiotics: current and future methods of administration.

Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses.

Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications

Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.

Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.

Inhaled insulin: too soon to be forgotten?

Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.

P304

1121-1126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.24397

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chrysanthi Sardeli

Ekaterini Amaniti

Kosmidis Ch

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29581792

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5868180

http://www.w3.org/2001/XMLSchema#string